Attached files
| file | filename |
|---|---|
| EX-21 - EX-21 - Cardiff Oncology, Inc. | a15-1864_1ex21.htm |
| EX-32.2 - EX-32.2 - Cardiff Oncology, Inc. | a15-1864_1ex32d2.htm |
| EX-10.7 - EX-10.7 - Cardiff Oncology, Inc. | a15-1864_1ex10d7.htm |
| EX-31.1 - EX-31.1 - Cardiff Oncology, Inc. | a15-1864_1ex31d1.htm |
| EX-31.2 - EX-31.2 - Cardiff Oncology, Inc. | a15-1864_1ex31d2.htm |
| EX-10.8 - EX-10.8 - Cardiff Oncology, Inc. | a15-1864_1ex10d8.htm |
| EX-10.6 - EX-10.6 - Cardiff Oncology, Inc. | a15-1864_1ex10d6.htm |
| EX-32.1 - EX-32.1 - Cardiff Oncology, Inc. | a15-1864_1ex32d1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Cardiff Oncology, Inc. | Financial_Report.xls |
| 10-K - 10-K - Cardiff Oncology, Inc. | a15-1864_110k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Trovagene, Inc.
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-186196) and Form S-8 (No. 333-190415) of Trovagene, Inc. of our reports dated March 12, 2015, relating to the consolidated financial statements, and the effectiveness of Trovagene, Inc.’s internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO USA, LLP
San Diego, California
March 12, 2015